A Prospective, Observational, Open-Label Study Investigating the Effectiveness and Safety of Ledipasvir/Sofosbuvir in Adolescents with Hepatitis C Virus Genotype 4 Infection
Latest Information Update: 01 Oct 2018
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 01 Oct 2018 New trial record
- 18 Sep 2018 Results published in the Pediatric Infectious Disease Journal